Ardent Health, Inc. (ARDT)
NYSE: ARDT · Real-Time Price · USD
14.62
+0.22 (1.53%)
Oct 7, 2025, 4:00 PM EDT - Market closed
Ardent Health Revenue
Ardent Health had revenue of $1.65B in the quarter ending June 30, 2025, with 11.85% growth. This brings the company's revenue in the last twelve months to $6.20B, up 10.03% year-over-year. In the year 2024, Ardent Health had annual revenue of $5.97B with 10.29% growth.
Revenue (ttm)
$6.20B
Revenue Growth
+10.03%
P/S Ratio
0.33
Revenue / Employee
$248,941
Employees
24,900
Market Cap
2.09B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 5.97B | 556.59M | 10.29% |
Dec 31, 2023 | 5.41B | 279.80M | 5.45% |
Dec 31, 2022 | 5.13B | 259.29M | 5.32% |
Dec 31, 2021 | 4.87B | 708.52M | 17.02% |
Dec 31, 2018 | 4.16B | 1.16B | 38.79% |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2004 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2003 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
ARDT News
- 15 days ago - Ardent Announces Successful Amendment and Extension of Term Loan Facility - Business Wire
- 4 weeks ago - Ardent Health, Inc. (ARDT) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript - Seeking Alpha
- 6 weeks ago - Ardent Health to Participate in September Investor Conferences - Business Wire
- 2 months ago - Ardent Health Reports Second Quarter 2025 Results - Business Wire
- 2 months ago - Ardent Health Announces Second Quarter 2025 Results Conference Call and Webcast Date - Business Wire
- 2 months ago - Ardent Health: The Best Prospect In An Industry That's Facing Challenges - Seeking Alpha
- 4 months ago - Ardent Health Partners, Inc. Updates Name to Ardent Health, Inc. - Business Wire
- 5 months ago - Ardent Health Appoints Chief Development Officer to Lead Strategic Growth - Business Wire